The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SKP SKYEPHARMA PLC ORD 100P



Income Statement  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  58.10 55.20 49.90 62.60 73.80
Operating Profit/(Loss)  14.50 9.80 17.10 13.60 21.60
Net Interest  12.30 0.40 11.80 14.10 7.00
Profit Before Tax  6.50 -1.00 -10.40 -1.00 -9.90
Profit After Tax  6.30 -1.60 -10.60 0.80 -10.50
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  6.30 -1.60 -10.60 0.80 -10.50
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  6.30 -1.60 -10.60 0.80 -10.50
 
Continuing EPS
Earnings per Share - Basic  26.30p -6.70p -36.00p 1.80p -12.30p
Earnings per Share - Diluted  15.30p -6.70p -36.00p 1.70p -12.30p
Earnings per Share - Adjusted  29.60p 1.90p 1.10p 1.80p 18.80p
Continuing and Discontinued EPS
Earnings per Share - Basic  26.30p -6.70p -14.90p 1.80p -12.30p
Earnings per Share - Diluted  15.30p -6.70p -14.90p 1.70p -12.30p
Earnings per Share - Adjusted  29.60p 1.90p 22.20p 1.80p 18.80p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  29.50 29.80 31.90 28.50 21.60
Intangible Assets  8.40 5.80 5.10 5.30 6.10
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.10 4.20 0.00 0.00 3.90
  38.00 39.80 37.00 33.80 31.60
Current Assets
Inventories  1.30 0.80 5.80 8.80 10.40
Trade & Other Receivables  11.50 10.50 13.30 15.50 16.60
Cash at Bank & in Hand  29.00 15.20 16.40 16.50 32.40
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  4.20 0.00 0.00 0.00 0.00
  46.00 26.50 35.50 40.80 59.40
 
Total Assets  84.00 66.30 72.50 74.60 91.00
 
Liabilities
Current Liabilities
Borrowings  -27.30 -19.60 -10.10 -9.80 -5.60
Other Current Liabilities  -17.70 -14.80 -24.20 -23.70 -33.40
  -45.00 -34.40 -34.30 -33.50 -39.00
 
Net Current Assets  1.00 -7.90 1.20 7.30 20.40
 
Non-Current Liabilities
Borrowings  -100.00 -94.60 -87.00 -90.90 -11.80
Provisions  0.00 -5.10 -5.30 -0.10 -0.20
Other Non-Current Liabilities  -18.90 -13.90 -11.90 -14.70 -12.80
  -118.90 -113.60 -104.20 -105.70 -24.80
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -163.90 -148.00 -138.50 -139.20 -63.80
 
Net Assets  -79.90 -81.70 -66.00 -64.60 27.20
 
Capital & Reserves
Share Capital  98.50 98.50 120.70 120.70 179.40
Share Premium Account  390.20 390.20 361.70 361.70 407.20
Other Reserves  -16.40 -16.80 -16.40 -16.20 -16.60
Retained Earnings  -552.20 -553.60 -532.00 -530.80 -542.80
Shareholders Funds  -79.90 -81.70 -66.00 -64.60 27.20
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  -79.90 -81.70 -66.00 -64.60 27.20

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  1.06 18.82 65.00 62.64 17.82
PEG - Adjusted  0.00 -0.20 -1.54 0.98 0.02
Earnings per Share Growth - Adjusted  2959900.00% -93.58% -42.11% 63.64% 944.44%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  242.08p 230.00p 169.15p 135.79p 86.52p
Pre-Tax Profit per Share  27.08p -4.17p -35.25p -2.17p -11.61p
Operating Margin  31.33% -1.45% 2.40% 20.77% -4.07%
Return on Capital Employed  42.63% -1.89% 4.47% 37.43% -6.50%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  -368.79p -365.45p -154.14p -151.53p 20.13p
Net Gearing  -123.03% -121.18% -122.27% -130.34% -55.15%

Data is provided by Morningstar

Market

Company Information
Updated Monthly
Company address 46-48 Grosvenor Gardens, London, SW1W 0EB, United Kingdom
Company website http://www.skyepharma.c...
Market cap(in millions)* £ 295.57
Listing/Admission to trading 03 May 1996
Trading service -
Market -
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
30-Jul-15
FTSE index FTSE All-Share,FTSE SmallCap,FTSE techMARK Focus,FTSE SmallCap (ex IT),FTSE techMARK mediscience,FTSE techMARK All-Share,FTSE All-Share (ex IT)
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



SKYEPHARMA share - fundamentals